MoonLake Immunotherapeutics (MLTX) Price Target Raised to $45 At H.C. Wainwright on FDA Progress
We recently compiled a list of the 8 Best Immunology Stocks to Buy According to Hedge Funds . MoonLake Immunotherapeutics (NASDAQ:MLTX) is among the best immunology stocks. TheFly reported on May 11 that H.C. Wainwright increased its price objective on MLTX to $45 from $40 while
Yahoo Finance โ 2 June 2026
Text:
14
0
0
We recently compiled a list of the 8 Best Immunology Stocks to Buy According to Hedge Funds . MoonLake Immunotherapeutics (NASDAQ:MLTX) is among the b
Sources

